Tektrotyd is a radiopharmaceutical indicated for the diagnosis of gastro-entero-pancreatic neuroendocrine tumours (GEP-NET).

Advantages:

  • One day patient imaging
  • High resolution images
  • A low radiation dose to patients
  • Simple preparation and 4hr storage of the kit once radiolabelled